MassIVE MSV000093905

Complete Public PXD048812

Quantitative Proteomics of axon regeneration promoted by Gangliosides and MTOR-Activating Small Molecules

Description

The ability to regenerate damaged central nervous system (CNS) axons of existing neurons is a significant challenge in treating conditions of neurodegenerative disorders such as glaucoma. To achieve neuroregeneration, we evaluated small molecules to target the MTOR pathway for axonal growth. In this study, 3-month-old C57BL/6J mice with equal gender distribution, a total of 2 lipid gangliosides and 4 small molecules were used. These are vehicle only, GM1, GM3, V0-Ophic, 3BDO, and Rapamycin. For each mouse, optic nerve crush was performed in one eye. At 2 days post injury, the same eye had an intravitreal injection of one or a combination of the small molecules noted above. Two days before euthanasia (Day 12), fluorophore 488 coupled cholera toxin B (CTB-488) was injected intravitreally for axonal imaging at endpoints. After animals were euthanized, optic nerves were collected by dissection. Three identical biological replicates for each treatment group (that were not injected with CTB-488) were analyzed by mass spectrometry. Protein extraction was carried out by homogenization of the tissue in extraction buffer (Triethylammonium bicarbonate buffer, Sodium Chloride and Sodium dodecyl sulfate). Protein amounts were estimated and normalized across experimental samples via densitometry. Samples were reduced using Tris(2-carboxyethyl) phosphine hydrochloride, alkylated with iodoacetamide, and digested overnight with trypsin. TMT (Tandem Mass Tag) labelling was carried out using 3 sets of 13 tags from a 16plex TMT kit for quantification. Samples were combined, dried, and fractionated. Untargeted liquid chromatography-mass spectrometry was performed on an Easy-nLC 1000 liquid chromatograph coupled to a QExactive mass spectrometer (LC-MS/MS). Data analysis was performed using Proteome Discoverer 3.0 and Graph Pad Prism 10. Raw mass spectrometry data files were analyzed using Proteome Discoverer 3.0. The mouse proteome was downloaded from UniProt and used as the target database for protein identification. Max missed cleavage site was set to 2 and minimum peptide length to 6. Precursor Mass Tolerance was set to 10ppm and Fragment Mass Tolerance to 0.02 Da. Post-translational modifications for experimental proteins included oxidation, acetylation, carbamidomethylation and TMTpro. The Normalization was set to total peptide amount and confidence to low. [doi:10.25345/C5JH3DD23] [dataset license: CC0 1.0 Universal (CC0 1.0)]

Keywords: Axon Regeneration, Quantitative Proteomics, TMT labeled, Mouse, Optic Nerve

Contact

Principal Investigators:
(in alphabetical order)
Sanjoy Bhattacharya, University of Miami, N/A
Submitting User: sbhattacharya
Number of Files:
Total Size:
Spectra:
Subscribers:
 
Owner Reanalyses
Experimental Design
    Conditions:
    Biological Replicates:
    Technical Replicates:
 
Identification Results
    Proteins (Human, Remapped):
    Proteins (Reported):
    Peptides:
    Variant Peptides:
    PSMs:
 
Quantification Results
    Differential Proteins:
    Quantified Proteins:
 
Browse Dataset Files Browse Results
 
FTP Download Link (click to copy):

- Dataset Reanalyses


+ Dataset History


Click here to queue conversion of this dataset's submitted spectrum files to open formats (e.g. mzML). This process may take some time.

When complete, the converted files will be available in the "ccms_peak" subdirectory of the dataset's FTP space (accessible via the "FTP Download" link to the right).
Number of distinct conditions across all analyses (original submission and reanalyses) associated with this dataset.

Distinct condition labels are counted across all files submitted in the "Metadata" category having a "Condition" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct biological replicates across all analyses (original submission and reanalyses) associated with this dataset.

Distinct replicate labels are counted across all files submitted in the "Metadata" category having a "BioReplicate" or "Replicate" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct technical replicates across all analyses (original submission and reanalyses) associated with this dataset.

The technical replicate count is defined as the maximum number of times any one distinct combination of condition and biological replicate was analyzed across all files submitted in the "Metadata" category. In the case of fractionated experiments, only the first fraction is considered.

"N/A" means no results of this type were submitted.
Originally identified proteins that were automatically remapped by MassIVE to proteins in the SwissProt human reference database.

"N/A" means no results of this type were submitted.
Number of distinct protein accessions reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct unmodified peptide sequences reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct peptide sequences (including modified variants or peptidoforms) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Total number of peptide-spectrum matches (i.e. spectrum identifications) reported across all analyses (original submission and reanalyses) associated with this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins quantified across all analyses (original submission and reanalyses) associated with this dataset.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
Number of distinct proteins found to be differentially abundant in at least one comparison across all analyses (original submission and reanalyses) associated with this dataset.

A protein is differentially abundant if its change in abundance across conditions is found to be statistically significant with an adjusted p-value <= 0.05 and lists no issues associated with statistical tests for differential abundance.

Distinct protein accessions are counted across all files submitted in the "Statistical Analysis of Quantified Analytes" category having a "Protein" column in this dataset.

"N/A" means no results of this type were submitted.
This dataset may not contain all raw spectra data as originally deposited in PRIDE. It has been imported to MassIVE for reanalysis purposes, so its spectra data here may consist solely of processed peak lists suitable for reanalysis with most software.